Blind Spots in the Endocrinology Clinic: Why Diabetes Specialists Must Become the Next Line of Defense Against Tuberculosis
A High-Risk Population Hidden in Plain Sight
Every week, endocrinology clinics across the United States see patients who carry one of the most significant risk factors for active tuberculosis — and most clinicians in those rooms have no formal training to recognize it. Diabetes mellitus, now diagnosed in more than 37 million Americans, is among the most potent biological amplifiers of tuberculosis risk known to medicine. Individuals living with diabetes are two to three times more likely to develop active TB than those without the condition, a consequence of the chronic immune dysregulation that defines the disease.
Yet the clinical world has largely failed to connect these two epidemics. Endocrinologists are trained to manage glycemic control, prevent cardiovascular complications, and monitor kidney function. Infectious disease — and tuberculosis in particular — rarely enters their curriculum in any meaningful depth. The result is a growing population of high-risk patients cycling through specialty appointments where no one is asking the questions that could save their lives.
The Immunological Link That Medical Training Ignores
To understand why diabetes and tuberculosis form such a dangerous pairing, it is necessary to examine what elevated blood glucose does to the body's immune architecture. Chronic hyperglycemia impairs neutrophil function, disrupts macrophage activity, and blunts the T-cell responses that are essential for containing Mycobacterium tuberculosis once it enters the lungs. In practical terms, this means that a diabetic patient who inhales TB bacilli is far less equipped to keep the infection in its latent, contained state — and far more likely to progress toward active, transmissible disease.
This relationship is not new to the scientific literature. Studies have documented it extensively for more than two decades. What remains stubbornly unchanged is the clinical response. TB specialists who treat co-infected patients describe a recurring pattern: by the time a diabetes patient arrives at a TB clinic, the disease has often been symptomatic for months. Cough, fatigue, and night sweats — symptoms that might prompt a pulmonologist or infectious disease physician to order a TB test — are frequently attributed to poorly controlled diabetes, respiratory allergies, or general deconditioning in the endocrinology setting.
"We see patients who have been managing their A1C for years with an excellent endocrinologist, and no one ever thought to ask about TB exposure," said one infectious disease specialist practicing in a high-burden urban county in the Southwest. "The metabolic focus is understandable. But it creates a blind spot that we are paying for in delayed diagnoses."
Where Cross-Disciplinary Training Breaks Down
The gap is not a matter of negligence. It is structural. American medical education organizes specialty training into silos that reflect the administrative architecture of healthcare delivery rather than the biological complexity of disease. An endocrinology fellow completing training at a major academic medical center may spend thousands of hours studying insulin resistance, thyroid pathology, and adrenal disorders without a single dedicated session on TB screening protocols, latent infection management, or the interpretation of an interferon-gamma release assay.
Continuing medical education requirements do little to fill this void. TB-specific content rarely appears on endocrinology board examinations, and professional societies in the diabetes space have been slow to integrate infectious disease guidance into their clinical practice frameworks. The American Diabetes Association's Standards of Medical Care in Diabetes, the field's most authoritative guidance document, addresses immunization recommendations and general infection risk but stops well short of a structured TB screening protocol.
This is a policy failure as much as an educational one. Public health agencies and professional medical organizations have not yet established clear, enforceable expectations for TB screening within endocrinology practice — leaving individual clinicians to navigate the issue without institutional support.
What a Practical Screening Protocol Could Look Like
There is no shortage of workable solutions. TB specialists and infectious disease physicians consulted by the StopTB Initiative describe a relatively straightforward set of interventions that endocrinology practices could implement without restructuring their clinical workflow.
The first step is risk stratification at intake. Patients with diabetes who were born in or have traveled to high-burden countries — including large portions of South Asia, sub-Saharan Africa, and Latin America — should be flagged for TB screening as a routine part of their initial evaluation. The same applies to patients with a history of homelessness, incarceration, or residence in congregate settings, all of which overlap significantly with diabetic populations in safety-net healthcare systems.
Once flagged, the pathway is clear: an interferon-gamma release assay (IGRA) or tuberculin skin test, followed by a chest radiograph if the result is positive. For patients with confirmed latent TB infection, a referral to a TB clinic or infectious disease provider should be initiated without delay. The entire process requires no specialized equipment and minimal additional clinical time.
"If you can add a depression screening tool and a fall-risk assessment to a diabetes visit, you can add a two-question TB exposure history," noted a diabetes care and education specialist working with a federally qualified health center in a high-prevalence metropolitan area. "It is about building the habit and giving clinicians the language to have the conversation."
Electronic health record systems could accelerate adoption significantly. Automated prompts that flag diabetic patients meeting high-risk demographic criteria for TB screening — similar to the reminders already used for colorectal cancer screening and annual flu vaccination — would reduce dependence on individual clinician recall and standardize the approach across practice settings.
The Advocacy Gap and Who Must Fill It
Advancing this agenda requires more than good intentions from individual providers. It demands coordinated action from multiple directions simultaneously. TB programs at state and local health departments need to build formal outreach relationships with endocrinology societies and diabetes care networks, providing training resources, consultation pathways, and data on local TB burden that makes the risk tangible for specialists who rarely encounter active cases.
Federal health agencies, including the Centers for Disease Control and Prevention and the Health Resources and Services Administration, have existing frameworks for integrating TB screening into primary care settings. Extending that infrastructure explicitly to specialty clinics — and to endocrinology in particular — would represent a cost-effective expansion of the nation's TB detection capacity.
Medical schools and residency programs bear responsibility as well. Incorporating TB-diabetes co-infection into endocrinology training curricula, even in a single dedicated session, would begin to shift the clinical culture toward greater awareness. What clinicians learn during formative training shapes what they notice — and what they miss — for the rest of their careers.
A Convergence America Cannot Afford to Ignore
The United States faces two overlapping public health challenges: a diabetes epidemic that shows no signs of abating, and a tuberculosis resurgence that is quietly reversing decades of hard-won progress. The intersection of these two diseases represents one of the most underaddressed vulnerabilities in American medicine.
Endocrinologists are not expected to become TB specialists. But they are positioned — often uniquely so — to identify patients at elevated risk before the disease declares itself in ways that are far more difficult and expensive to treat. Equipping them with the knowledge and the tools to act on that position is not an unreasonable ask. It is, at this moment in American public health, an urgent one.
